Portal hypertension predicts short-term and long-term outcomes after hepatectomy in hepatocellular carcinoma patients

References

• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.
   PubMed Web of Science ®Google Scholar
• Sherman M. Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Semin Liver Dis. 2010;30:3–16.
   PubMed Web of Science ®Google Scholar
• Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371:838–851.
   PubMed Web of Science ®Google Scholar
• Abraldes JG, Bureau C, Stefanescu H, et al. Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: the "Anticipate" study. Hepatology. 2016;64:2173–2184.
   PubMed Web of Science ®Google Scholar
• Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012;379:1245–1255.
   PubMed Web of Science ®Google Scholar
• Chen X, Zhai J, Cai X, et al. Severity of portal hypertension and prediction of postoperative liver failure after liver resection in patients with Child–Pugh grade A cirrhosis. Br J Surg. 2012;99:1701–1710.
   PubMed Web of Science ®Google Scholar
• Allard MA, Adam R, Bucur PO, et al. Posthepatectomy portal vein pressure predicts liver failure and mortality after major liver resection on noncirrhotic liver. Ann Surg. 2013;258:822. discussion 829–830.
   PubMed Web of Science ®Google Scholar
• Berzigotti A, Reig M, Abraldes JG, et al. Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis. Hepatology. 2015;61:526–536.
   PubMed Web of Science ®Google Scholar
• Hidaka M, Takatsuki M, Soyama A, et al. Intraoperative portal venous pressure and long-term outcome after curative resection for hepatocellular carcinoma. Br J Surg. 2012;99:1284–1289.
   PubMed Web of Science ®Google Scholar
• Torzilli G, Belghiti J, Kokudo N, et al. A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: an observational study of the HCC East-West study group. Ann Surg. 2013;257:929–937.
   PubMed Web of Science ®Google Scholar
• Cucchetti A, Ercolani G, Vivarelli M, et al. Is portal hypertension a contraindication to hepatic resection? Ann Surg. 2009;250:922–928.
   PubMed Web of Science ®Google Scholar
• Ishizawa T, Hasegawa K, Aoki T, et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology. 2008;134:1908–1916.
   PubMed Web of Science ®Google Scholar
• Giannini EG, Savarino V, Farinati F, et al. Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. Liver Int. 2013;33:1594–1600.
   PubMed Web of Science ®Google Scholar
• Zou H, Wen Y, Yuan K, et al. Combining albumin-bilirubin score with future liver remnant predicts posthepatectomy liver failure in HBV-associated HCC patients. Liver Int. 2018;38:494–502.
   PubMed Web of Science ®Google Scholar
• Mullen JT, Ribero D, Reddy SK, et al. Hepatic insufficiency and mortality in 1059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg. 2007;204:854–862. discussion 862–864.
   PubMed Web of Science ®Google Scholar
• Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–213.
   PubMed Web of Science ®Google Scholar
• Balzan S, Belghiti J, Farges O, et al. The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg. 2005;242:824. discussion 828–829.
   PubMed Web of Science ®Google Scholar
• Rahbari NN, Garden OJ, Padbury R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011;149:713–724.
   PubMed Web of Science ®Google Scholar
• Hackl C, Schlitt HJ, Renner P, et al. Liver surgery in cirrhosis and portal hypertension. World J Gastroenterol. 2016;22:2725–2735.
   PubMed Web of Science ®Google Scholar
• Pessaux P, Msika S, Atalla D, et al. Risk factors for postoperative infectious complications in noncolorectal abdominal surgery: a multivariate analysis based on a prospective multicenter study of 4718 patients. Arch Surg. 2003;138:314–324.
   PubMedGoogle Scholar
• Hernandez-Gea V, Turon F, Berzigotti A, et al. Management of small hepatocellular carcinoma in cirrhosis: focus on portal hypertension. WJG. 2013;19:1193–1199.
   PubMed Web of Science ®Google Scholar
• Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. JCO. 2015;33:550–558.
   PubMed Web of Science ®Google Scholar
• Kishi Y, Abdalla EK, Chun YS, et al. Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry. Ann Surg. 2009;250:540–548.
   PubMed Web of Science ®Google Scholar
• Khan AS, Garcia-Aroz S, Ansari MA, et al. Assessment and optimization of liver volume before major hepatic resection: current guidelines and a narrative review. Int J Surg. 2018;52:74–81.
   PubMed Web of Science ®Google Scholar
• Zou H, Yang X, Li QL, et al. A comparative study of albumin-bilirubin score with Child–Pugh Score, Model for End-Stage Liver Disease Score and Indocyanine Green R15 in predicting posthepatectomy liver failure for hepatocellular carcinoma patients. Dig Dis. 2018;36:236–243.
   PubMed Web of Science ®Google Scholar
• Bruix J, Gores GJ, Mazzaferro V. Hepatocellular carcinoma: clinical frontiers and perspectives. Gut. 2014;63:844–855.
   PubMed Web of Science ®Google Scholar
• Hwang S, Lee YJ, Kim KH, et al. The impact of tumor size on long-term survival outcomes after resection of solitary hepatocellular carcinoma: single-institution experience with 2558 patients. J Gastrointest Surg. 2015;19:1281–1290.
   PubMed Web of Science ®Google Scholar
• Ho MC, Hasegawa K, Chen XP, et al. Surgery for intermediate and advanced hepatocellular carcinoma: a consensus report from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014). Liver Cancer. 2016;5:245–256.
   PubMed Web of Science ®Google Scholar
• Bolondi L, Burroughs A, Dufour JF, et al. Heterogeneity of patients with intermediate (BCLC B) hepatocellular carcinoma: proposal for a subclassification to facilitate treatment decisions. Semin Liver Dis. 2012;32:348–359.
   PubMed Web of Science ®Google Scholar
• Yin L, Li H, Li AJ, et al. Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan Criteria: a RCT. J Hepatol. 2014;61:82–88.
   PubMed Web of Science ®Google Scholar